GleamWall
中文EN

Decheng Capital LLC

MENLO PARK CA · SEC CIK 0002010850

2026Q22026Q1 9 earlier quarters 🔒
$731.75M2026Q2 reported value
14Positions
98.1%Top 10 weight · largest 61.9%
1 / 1New / sold out
Reported value over time$731.75M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

CGON 61.9%
NUVB 20.1%
AARDVARK THERA 3.1%
ACRS 2.9%
UPB 2.6%
RCUS 2.0%
EQ 1.9%
RVMD 1.3%
Lyell Immunoph 1.3%
BeyondSpring I 0.9%

2026Q2 top buys estimated at quarter-end value

TNGX New+$625,200

2026Q2 top sells estimated at quarter-end value

RVMD Reduced-$7.65M
NAMS Reduced-$5.02M
KRYS Sold out-$1.89M
RCUS Reduced-$402,023

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
CGON CG ONCOLOGY INC $452.71M61.87%6,371,669 00.0% — Unchanged
NUVB Nuvation Bio Inc. $147.42M20.15%25,954,439 00.0% — Unchanged
— AARDVARK THERAPEUTICS INC $22.56M3.08%3,917,299 00.0% — Unchanged
ACRS Aclaris Therapeutics, Inc. $21.38M2.92%4,041,736 00.0% — Unchanged
UPB Upstream Bio Inc. $18.86M2.58%2,724,868 00.0% — Unchanged
RCUS Arcus Biosciences, Inc $14.33M1.96%464,779 -13,040-2.7% -$402,023 Reduced
EQ Equillium Inc. $14.23M1.94%4,447,308 00.0% — Unchanged
RVMD REVOLUTION MEDICINES INC(NSM) $9.86M1.35%52,667 -40,833-43.7% -$7.65M Reduced
— Lyell Immunopharma, Inc. $9.72M1.33%692,050 00.0% — Unchanged
— BeyondSpring Inc. $6.65M0.91%3,800,702 00.0% — Unchanged
ZNTL Zentalis Pharmaceuticals Inc. $6.42M0.88%1,323,327 00.0% — Unchanged
NAMS NEWAMSTERDAM PHARMA CO NV $5.99M0.82%176,887 -148,170-45.6% -$5.02M Reduced
— Pyxis Oncology, Inc (formerly Apexigen) $983,6980.13%326,810 00.0% — Unchanged
TNGX TANGO THERAPEUTICS INC $625,2000.09%20,000 20,000— $625,200 New
KRYS KRYSTAL BIOTECH INC $00.00%0 -7,300-100.0% -$1.89M Sold out